Skip to main content
Gift Cards Available Online! Shop Now!

Renew iv Blog


Unleash Your Cellular Vitality with NAD+ Consultations at Renew IV in Louisville, Boulder, and Lafayette, CO | 303-467-3639 Renew Movement

Unleash Your Cellular Vitality with NAD+ Consultations at Renew IV

March 27, 2024
Embark on a journey to rejuvenation and optimized wellness with NAD+ consultations, now available at Renew IV. In this SEO-optimized blog post, we’ll explore the incredible benefits of NAD+ therapy, why…

Drop in Triglycerides, Drop in A1C

February 3, 2022
We have another client who has impressive blood work changes after starting IVs. Here’s the scoop. Client is 68 and female. Had chronically high triglycerides, hypertension, and struggles with A1C and pre-d…

Cholesterol and NAD+ (see the blood work results!)

February 3, 2022
Total cholesterol 232 to 178Triglycerides 432 to 291(in 6 weeks) The above blood work was shared by a Renew iv client. They came in for a Thrive iv + NAD+ on September 4th. One week after they received t…

The ‘Why’ Behind Renew iv – Getting Personal with the Founder

February 1, 2022
Renew Movement™ recently launched Renew iv and the ‘why’ behind the business is both heartbreaking and inspiring. The story of how it became involves a long-fought battle against autoimmune disease, food al…

Our COVID Story

December 30, 2021
My husband, Corin, and I contracted covid. We’re both vaccinated (him Pfizer, me J&J). Neither of us had the vaccine booster when we got sick. Here’s our story. 10/31: Corin felt like he had a cold. …

Therapeutic potential of boosting NAD+ in aging and age-related diseases

October 5, 2021
Abstract Nicotinamide adenine dinucleotide (NAD+) is an essential cofactor in all living cells that is involved in fundamental biological processes. NAD+ depletion has been associated with…

Welcome to the Renew iv Blog

We bring you information about wellness.

Follow us

Stay connected

Sign up for email updates to receive all of our latest news

  • This field is for validation purposes and should be left unchanged.